Following New York state guidance, MSK has suspended offering the J & J/Janssen vaccine. We continue to offer the Pfizer-BioNTech and Moderna vaccines to our eligible patients. Appointments can be scheduled here. For more on the J & J vaccine, read this.
Victoria Gutgarts, MD
Acute Kidney Injury; Chronic Kidney Disease; Electrolyte Abnormalities; Kidney Injury Related to Bone Marrow Transplantation and Chemotherapy
Internal Medicine - Montefiore Medical Center/Albert Einstein College of Medicine
Nephrology - Weill Cornell Medical Center/ NewYork-Presbyterian; Onconephrology - Memorial Sloan Kettering Cancer Center
Internal Medicine; Nephrology
I am a board-certified kidney specialist. I treat a spectrum of conditions varying from acute to chronic kidney disease and electrolyte abnormalities. After my nephrology training at Weill Cornell Medical Center, I spent additional time training at Memorial Sloan Kettering Cancer Center, where I subspecialized in onconephrology to sharpen my understanding of kidney issues associated with cancer. During my inpatient and outpatient consultations, I strive to provide clear explanations and answer any questions to the best of my ability. I aim to comfort my patients and instill a sense of trust and teamwork with them.
I am a member of several nephrology societies, including the American Society of Nephrology. I have attended and presented at national conferences. My current research interest is kidney injury in people who have undergone bone marrow transplantation. I am also interested in identifying early markers of kidney injury through novel urine biomarkers. I am always eager to collaborate with my oncology colleagues at Memorial Sloan Kettering with the ultimate goal of performing meaningful and thoughtful research to help our patients.
I aim to comfort my patients and instill a sense of trust and teamwork with them.
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Victoria Gutgarts discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at email@example.com.